vs
Esperion Therapeutics, Inc.（ESPR）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Ribbon Communications Inc.的1.0倍（$168.4M vs $162.6M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -10.3%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -8.1%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
ESPR vs RBBN — 直观对比
营收规模更大
ESPR
是对方的1.0倍
$162.6M
营收增速更快
ESPR
高出154.0%
-10.3%
两年增速更快
ESPR
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $162.6M |
| 净利润 | — | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | 50.6% | 37.6% |
| 净利率 | — | 54.8% |
| 营收同比 | 143.7% | -10.3% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $168.4M | $227.3M | ||
| Q3 25 | $87.3M | $215.4M | ||
| Q2 25 | $82.4M | $220.6M | ||
| Q1 25 | $65.0M | $181.3M | ||
| Q4 24 | $69.1M | $251.4M | ||
| Q3 24 | $51.6M | $210.2M | ||
| Q2 24 | $73.8M | $192.6M |
净利润ESPRRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-12.1M | ||
| Q2 25 | $-12.7M | $-11.1M | ||
| Q1 25 | $-40.5M | $-26.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-13.4M | ||
| Q2 24 | $-61.9M | $-16.8M |
毛利率ESPRRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率ESPRRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 50.6% | 4.1% | ||
| Q3 25 | -11.4% | 1.3% | ||
| Q2 25 | 8.6% | 1.9% | ||
| Q1 25 | -34.0% | -10.8% | ||
| Q4 24 | -6.4% | 13.2% | ||
| Q3 24 | -31.0% | -0.4% | ||
| Q2 24 | 3.5% | -1.0% |
净利率ESPRRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -5.6% | ||
| Q2 25 | -15.4% | -5.0% | ||
| Q1 25 | -62.2% | -14.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -6.4% | ||
| Q2 24 | -83.9% | -8.7% |
每股收益（稀释后）ESPRRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.32 | $0.50 | ||
| Q3 25 | $-0.16 | $-0.07 | ||
| Q2 25 | $-0.06 | $-0.06 | ||
| Q1 25 | $-0.21 | $-0.15 | ||
| Q4 24 | $-0.14 | $0.05 | ||
| Q3 24 | $-0.15 | $-0.08 | ||
| Q2 24 | $-0.33 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $419.1M |
| 总资产 | $465.9M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $167.9M | $96.4M | ||
| Q3 25 | $92.4M | $74.8M | ||
| Q2 25 | $86.1M | $60.5M | ||
| Q1 25 | $114.6M | $71.2M | ||
| Q4 24 | $144.8M | $87.8M | ||
| Q3 24 | $144.7M | $37.2M | ||
| Q2 24 | $189.3M | $64.6M |
总债务ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益ESPRRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $-302.0M | $449.0M | ||
| Q3 25 | $-451.4M | $360.1M | ||
| Q2 25 | $-433.5M | $370.4M | ||
| Q1 25 | $-426.2M | $381.8M | ||
| Q4 24 | $-388.7M | $404.6M | ||
| Q3 24 | $-370.2M | $395.5M | ||
| Q2 24 | $-344.2M | $405.0M |
总资产ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | $465.9M | $1.2B | ||
| Q3 25 | $364.0M | $1.1B | ||
| Q2 25 | $347.1M | $1.1B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.1B | ||
| Q2 24 | $352.3M | $1.1B |
负债/权益比ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $29.2M | ||
| Q3 25 | $-4.3M | $26.5M | ||
| Q2 25 | $-31.4M | $-795.0K | ||
| Q1 25 | $-22.6M | $-3.5M | ||
| Q4 24 | $-35.0M | $61.8M | ||
| Q3 24 | $-35.3M | $-14.8M | ||
| Q2 24 | $-7.2M | $-9.8M |
自由现金流ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $21.0M | ||
| Q2 25 | — | $-6.5M | ||
| Q1 25 | — | $-15.7M | ||
| Q4 24 | — | $53.8M | ||
| Q3 24 | $-35.5M | $-23.7M | ||
| Q2 24 | $-7.3M | $-12.9M |
自由现金流率ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | — | -2.9% | ||
| Q1 25 | — | -8.7% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | -68.7% | -11.3% | ||
| Q2 24 | -9.9% | -6.7% |
资本支出强度ESPRRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.0% | 6.7% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | 0.3% | 4.2% | ||
| Q2 24 | 0.1% | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
